T. T. Yee

2.1k total citations
42 papers, 1.2k citations indexed

About

T. T. Yee is a scholar working on Hematology, Genetics and Hepatology. According to data from OpenAlex, T. T. Yee has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 11 papers in Genetics and 10 papers in Hepatology. Recurrent topics in T. T. Yee's work include Hemophilia Treatment and Research (26 papers), Platelet Disorders and Treatments (11 papers) and Blood Coagulation and Thrombosis Mechanisms (11 papers). T. T. Yee is often cited by papers focused on Hemophilia Treatment and Research (26 papers), Platelet Disorders and Treatments (11 papers) and Blood Coagulation and Thrombosis Mechanisms (11 papers). T. T. Yee collaborates with scholars based in United Kingdom, United States and Italy. T. T. Yee's co-authors include C. A. Lee, John Pasi, Anja Griffioen, Michael Makris, Dirk Posthouwer, Kathelijn Fischer, Savita Rangarajan, Christine A. Lee, Joost J. van Veen and Karel J. van Erpecum and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

T. T. Yee

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. T. Yee United Kingdom 22 824 288 249 210 116 42 1.2k
William E. Beschorner United States 9 662 0.8× 123 0.4× 176 0.7× 84 0.4× 102 0.9× 11 1.1k
D Rafanelli Italy 18 376 0.5× 53 0.2× 73 0.3× 141 0.7× 52 0.4× 47 734
Martin Mohren Germany 17 321 0.4× 30 0.1× 91 0.4× 170 0.8× 98 0.8× 37 936
Françoise Driss France 11 287 0.3× 413 1.4× 440 1.8× 364 1.7× 52 0.4× 21 979
Önder Arslan Türkiye 16 354 0.4× 132 0.5× 201 0.8× 130 0.6× 53 0.5× 81 779
Martine J. Hollestelle Netherlands 16 411 0.5× 132 0.5× 116 0.5× 90 0.4× 133 1.1× 33 837
Anna Kreil Austria 11 121 0.1× 468 1.6× 416 1.7× 45 0.2× 58 0.5× 15 725
Valérie Eschwège France 9 329 0.4× 82 0.3× 120 0.5× 59 0.3× 171 1.5× 31 761
Günter Auerswald Germany 22 1.5k 1.8× 50 0.2× 52 0.2× 316 1.5× 160 1.4× 46 1.6k
Vinay Sakhuja India 16 146 0.2× 58 0.2× 138 0.6× 76 0.4× 123 1.1× 58 839

Countries citing papers authored by T. T. Yee

Since Specialization
Citations

This map shows the geographic impact of T. T. Yee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. T. Yee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. T. Yee more than expected).

Fields of papers citing papers by T. T. Yee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. T. Yee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. T. Yee. The network helps show where T. T. Yee may publish in the future.

Co-authorship network of co-authors of T. T. Yee

This figure shows the co-authorship network connecting the top 25 collaborators of T. T. Yee. A scholar is included among the top collaborators of T. T. Yee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. T. Yee. T. T. Yee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stasyshyn, Oleksandra, Margarita Timofeeva, Nicola Curry, et al.. (2018). Evaluation of the effect on endogenous factor VIII activity (FVIII: C) after recombinant von Willebrand factor (rVWF) administration during the elective surgery study in patients with severe von Willebrand disease (VWD). Haemophilia. 24. 107–108. 1 indexed citations
2.
Peyvandi, Flora, Oleksandra Stasyshyn, Margarita Timofeeva, et al.. (2018). Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery. Journal of Thrombosis and Haemostasis. 17(1). 52–62. 49 indexed citations
3.
Mannucci, Pier Mannuccio, Christine L. Kempton, Carolyn M. Millar, et al.. (2013). Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial. Blood. 122(5). 648–657. 87 indexed citations
4.
Mackensen, Sylvia von, Silvia Riva, Kate Khair, et al.. (2013). Development of an inhibitor-specific questionnaire for the assessment of health-related quality of life in haemophilia patients with inhibitors (INHIB-QoL). Value in Health. 16(3). A196–A196. 4 indexed citations
5.
Anderson, Julia A. M., et al.. (2013). Guidance on the dental management of patients with haemophilia and congenital bleeding disorders. BDJ. 215(10). 497–504. 71 indexed citations
6.
Mahlangu, Johnny, Michael Laffan, Jerzy Windyga, et al.. (2012). Phase I, randomized, double‐blind, placebo‐controlled, single‐dose escalation study of the recombinant factor VIIa variant BAY 86‐6150 in hemophilia. Journal of Thrombosis and Haemostasis. 10(5). 773–780. 29 indexed citations
7.
Cellerai, Cristina, Alexandre Harari, Hans J. Stauss, et al.. (2011). Early and Prolonged Antiretroviral Therapy Is Associated with an HIV-1-Specific T-Cell Profile Comparable to That of Long-Term Non-Progressors. PLoS ONE. 6(4). e18164–e18164. 37 indexed citations
8.
Sørensen, Benny, Gary Benson, Melanie Bladen, et al.. (2011). Management of muscle haematomas in patients with severe haemophilia in an evidence‐poor world. Haemophilia. 18(4). 598–606. 24 indexed citations
9.
Wilde, J, David Mutimer, G. Dolan, et al.. (2011). UKHCDO guidelines on the management of HCV in patients with hereditary bleeding disorders 2011. Haemophilia. 17(5). e877–83. 8 indexed citations
10.
Perry, David J., Erik Berntorp, Robert C. Tait, et al.. (2009). FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations. Haemophilia. 16(1). 80–89. 20 indexed citations
11.
Riddell, Anne, et al.. (2007). Acquired haemophilia masked by warfarin therapy. International Journal of Laboratory Hematology. 29(1). 64–68. 8 indexed citations
12.
Killingley, Ben, et al.. (2006). Tuberculosis complicating treatment of hepatitis C in an HIV‐infected haemophilia A patient. Haemophilia. 12(5). 545–547. 5 indexed citations
13.
Sabin, Caroline, Andrew Phillips, T. T. Yee, Anja Griffioen, & Christine A. Lee. (2005). Twenty five years of HIV infection in haemophilic men in Britain: an observational study. BMJ. 331(7523). 997–998. 6 indexed citations
14.
Yee, T. T. & Christine A. Lee. (2005). Transfusion-Transmitted Infection in Hemophilia in Developing Countries. Seminars in Thrombosis and Hemostasis. 31(5). 527–537. 12 indexed citations
15.
Sabin, Caroline, Anja Griffioen, T. T. Yee, et al.. (2002). Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. The Lancet. 360(9345). 1546–1551. 29 indexed citations
16.
Sabin, Caroline, Vincent C. Emery, Helen Devereux, et al.. (2002). Long‐term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders. Journal of Medical Virology. 68(1). 68–75. 4 indexed citations
17.
Yee, T. T., et al.. (2001). Multiple myeloma and human immunodeficiency virus-1 (HIV-1) infection. American Journal of Hematology. 66(2). 123–125. 12 indexed citations
18.
Yee, T. T., Alì Taher, John Pasi, & C. A. Lee. (2000). A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clinical & Laboratory Haematology. 22(5). 275–278. 50 indexed citations
19.
Yee, T. T., et al.. (2000). The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut. 47(6). 845–851. 141 indexed citations
20.
Yee, T. T., et al.. (1999). Factor VIII inhibitors in haemophiliacs: a single‐centre experience over 34 years, 1964–97. British Journal of Haematology. 104(4). 909–914. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William E. Beschorner Breakdown of academic impact, for papers by D Rafanelli Breakdown of academic impact, for papers by Martin Mohren Breakdown of academic impact, for papers by Françoise Driss Breakdown of academic impact, for papers by Önder Arslan Breakdown of academic impact, for papers by Martine J. Hollestelle Breakdown of academic impact, for papers by Anna Kreil Breakdown of academic impact, for papers by Valérie Eschwège Breakdown of academic impact, for papers by Günter Auerswald Breakdown of academic impact, for papers by Vinay Sakhuja
Rankless by CCL
2026